Vicor (VICR) Reaches $28.55 52-Week High; Lexicon Pharmaceuticals, Inc. (LXRX) Had 4 Bullish Analysts

The stock of Vicor Corporation (NASDAQ:VICR) hit a new 52-week high and has $30.83 target or 8.00% above today’s $28.55 share price. The 6 months bullish chart indicates low risk for the $1.13B company. The 1-year high was reported on Mar, 31 by Barchart.com. If the $30.83 price target is reached, the company will be worth $90.24 million more. The stock increased 9.81% or $2.55 during the last trading session, reaching $28.55. About 316,694 shares traded or 139.88% up from the average. Vicor Corporation (NASDAQ:VICR) has risen 53.14% since March 31, 2017 and is uptrending. It has outperformed by 41.59% the S&P500.

Among 9 analysts covering Lexicon Pharmaceuticals (NASDAQ:LXRX), 4 have Buy rating, 2 Sell and 3 Hold. Therefore 44% are positive. Lexicon Pharmaceuticals had 20 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was maintained by Needham on Tuesday, August 1 with “Buy”. The firm has “Underweight” rating by JP Morgan given on Wednesday, February 14. The stock of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) has “Buy” rating given on Friday, October 7 by H.C. Wainwright. The firm earned “Hold” rating on Tuesday, August 1 by Cowen & Co. J.P. Morgan downgraded Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) rating on Wednesday, February 14. J.P. Morgan has “Sell” rating and $10.0 target. Stifel Nicolaus maintained Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) rating on Friday, September 8. Stifel Nicolaus has “Buy” rating and $27.0 target. Wedbush maintained the shares of LXRX in report on Monday, August 7 with “Buy” rating. Citigroup initiated the shares of LXRX in report on Tuesday, August 2 with “Buy” rating. The company was maintained on Thursday, October 5 by Wedbush. The rating was downgraded by Needham to “Hold” on Friday, February 23. See Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) latest ratings:

12/03/2018 Broker: Wedbush Rating: Buy New Target: $38.0 Maintain
23/02/2018 Broker: Needham Rating: Hold Downgrade
14/02/2018 Broker: J.P. Morgan Rating: Sell New Target: $10.0 Downgrade
14/02/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Underweight Downgrade
30/11/2017 Broker: Wedbush Rating: Buy New Target: $38.0 Maintain
05/10/2017 Broker: Wedbush Rating: Buy New Target: $38.0 Maintain

Since December 8, 2017, it had 2 insider buys, and 3 insider sales for $100,273 activity. On Wednesday, December 13 the insider GRIFFIN LIAM sold $85,125. $71,348 worth of stock was bought by VINCIARELLI PATRIZIO on Thursday, December 14. $67,423 worth of Vicor Corporation (NASDAQ:VICR) was sold by Nagel Richard J Jr.

Investors sentiment decreased to 0.81 in Q4 2017. Its down 0.38, from 1.19 in 2017Q3. It dropped, as 6 investors sold Vicor Corporation shares while 37 reduced holdings. 12 funds opened positions while 23 raised stakes. 9.88 million shares or 0.41% more from 9.84 million shares in 2017Q3 were reported. Geode Capital Mgmt Ltd Llc holds 0% in Vicor Corporation (NASDAQ:VICR) or 134,104 shares. California Employees Retirement Systems invested in 0% or 27,200 shares. State Street reported 441,902 shares stake. The Georgia-based Atlantic Tru Gru Ltd Liability has invested 0.01% in Vicor Corporation (NASDAQ:VICR). Menta Lc invested 0.1% in Vicor Corporation (NASDAQ:VICR). Schwab Charles Invest Mngmt stated it has 0% of its portfolio in Vicor Corporation (NASDAQ:VICR). Moreover, Parametric Port Assocs Ltd Co has 0% invested in Vicor Corporation (NASDAQ:VICR). Assetmark reported 6 shares. Manufacturers Life Insurance The holds 0% or 13,652 shares. Invesco accumulated 12,217 shares or 0% of the stock. Mason Street Ltd Limited Liability Company has invested 0% in Vicor Corporation (NASDAQ:VICR). Teton Advsr Incorporated holds 0.06% or 33,000 shares. Great West Life Assurance Comm Can has invested 0% in Vicor Corporation (NASDAQ:VICR). Pnc Grp Incorporated owns 152 shares. Needham Investment Ltd Llc holds 0.62% or 112,200 shares.

Vicor Corporation designs, develops, makes, and markets modular components and power systems for converting, regulating, and controlling electric current worldwide. The company has market cap of $1.13 billion. It operates through Brick Business Unit, VI Chip, and Picor divisions. It has a 7137.5 P/E ratio. The firm offers modular direct current -DC converters and complementary components, open-frame intermediate bus converters, configurable products, and custom power systems, as well as cool-power high density zero voltage soft switching DC-DC converters.

The post Vicor (VICR) Reaches $28.55 52-Week High; Lexicon Pharmaceuticals, Inc. (LXRX) Had 4 Bullish Analysts appeared first on Stock Market News | HillCountryTimes | Get it Today.

from
https://www.hillcountrytimes.com/2018/03/31/vicor-vicr-reaches-28-55-52-week-high-lexicon-pharmaceuticals-inc-lxrx-had-4-bullish-analysts/